TransMedics Group, Inc.

TMDX

TransMedics Group, Inc.

TMDX

Insider Sentiment (TTM):

Last Purchase:2025-11-17Last Sale:2026-06-15Shares Purchased (TTM):17,250Shares Sold (TTM):42,659

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:35,204,893Shares Outstanding:34,384,207Institutional Ownership Pct.:102.39%

Earnings Market Reaction:

Filing Date:2026-05-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Electromedical & Electrotherapeutic Apparatus

MDT MASI LIVN ITGR AXGN CNMD

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash	462	488	466	401	310	337	330	363	350	395	427	582
Accounts Receivable Net Current	91	84	81	105	142	98	90	81	82	64	61	48
Inventory Net	50	49	45	39	43	47	52	49	49	44	39	31
Prepaid Expense And Other Assets Current	17	16	22	14	10	16	20	17	8	8	10	2
Assets Current	619	638	613	558	506	497	492	509	488	511	537	663
Property Plant And Equipment Net	362	328	313	312	311	286	272	229	214	174	131	20
Finance Lease Right Of Use Asset	335	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Asset	5	5	6	6	6	6	7	6	6	7	7	7
Deferred Income Tax Assets Net	82	84	-	-	-	-	-	-	-	-	-	-
Restricted Cash Noncurrent	18	1	1	1	1	1	1	1	1	1	1	1
Goodwill	12	12	12	12	12	12	12	12	12	12	12	-
Intangible Assets Net Excluding Goodwill	0	2	2	2	2	2	2	2	2	2	2	-
Other Assets Noncurrent	2	0	0	0	0	0	0	0	0	0	0	0
Assets	1,435	1,068	946	891	838	804	786	759	724	706	689	690
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	11	10	12	10	11	10	13	13	9	13	13	7
Accrued Liabilities And Other Liabilities	59	63	56	42	40	45	42	38	37	38	32	23
Long Term Debt Current	15	10	5	-	-	-	-	-	-	-	-	-
Contract With Customer Liability Current	3	3	3	2	2	2	2	1	2	2	3	0
Operating Lease Liability Current	4	3	3	3	3	3	3	2	2	2	2	2
Liabilities Current	92	89	80	57	56	60	60	54	50	55	49	32
Convertible Debt Noncurrent	454	453	452	451	451	450	449	449	448	447	446	446
Other Long Term Debt Noncurrent	45	50	55	60	59	59	59	59	59	59	59	59
Finance Lease Liability Noncurrent	344	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	3	4	4	5	6	6	7	7	7	8	8	8
Other Liabilities Noncurrent	4	-	-	-	-	-	-	-	-	-	-	-
Liabilities	941	595	591	572	571	575	576	569	564	569	563	545
Stockholders Equity
Common Stock Value	765	751	738	726	709	697	685	669	651	641	634	628
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-271	-278	-383	-408	-443	-468	-475	-479	-492	-504	-508	-482
Stockholders Equity	494	473	355	318	266	229	210	190	159	137	126	145
Liabilities And Stockholders Equity	1,435	1,068	946	891	838	804	786	759	724	706	689	690
Preferred Stock No Par Value	0	0	-	-	-	0	-	-	-	0	-	-
Preferred Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock No Par Value	0	0	-	-	-	0	-	-	-	0	-	-
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	35	34	34	34	34	34	34	33	33	33	33	33
Shares Outstanding	35	34	34	34	34	34	34	33	33	33	33	33

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-29.21%	-27.90%	-25.07%	-	-	-	-	-	-	-	-	-
2025	36.39%	41.04%	16.01%	11.28%	13.55%	9.22%	-2.52%	-4.95%	6.74%	-17.33%	-15.90%	-54.13%
2024	12.74%	11.73%	18.29%	15.94%	8.90%	-16.44%	-14.08%	-30.28%	-35.37%	-4.26%	22.35%	68.58%
2023	-	-	-	-22.12%	-31.01%	-48.46%	21.97%	28.95%	41.24%	-20.12%	-5.13%	55.54%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	6.74	7.14	7.69	9.86	9.10	8.30	8.20	9.37	9.72	9.30	10.93	20.70
Quick Ratio	6.01	6.41	6.86	8.93	8.13	7.25	7.00	8.17	8.60	8.34	9.93	19.67
Working Capital	527.36M	548.48M	533.28M	501.51M	450.32M	437.30M	432.43M	454.94M	438.08M	455.72M	487.62M	630.64M
Leverage & Debt
Debt to Equity	1.90	1.26	1.66	1.80	2.14	2.52	2.74	2.99	3.54	4.15	4.45	3.75
Interest Coverage TTM	5.40	7.88	6.85	5.42	3.68	2.60	2.18	-0.06	-1.07	-2.66	-4.65	-2.84
Debt Ratio	0.66	0.56	0.62	0.64	0.68	0.72	0.73	0.75	0.78	0.81	0.82	0.79
Efficiency & Turnover
Asset Turnover TTM	0.56	0.65	0.65	0.64	0.63	0.58	0.54	0.50	0.59	0.49	0.40	0.37
Days Sales Outstanding TTM	66.80	54.86	55.05	63.89	83.72	66.67	68.61	65.46	74.10	68.87	78.67	73.09
Receivables Turnover TTM	5.46	6.65	6.63	5.71	4.36	5.47	5.32	5.58	4.93	5.30	4.64	4.99
Per Share Metrics
Diluted EPS TTM	4.75	4.69	2.25	1.77	1.23	1.01	0.91	0.09	-0.29	-0.77	-1.10	-0.55
Free Cash Flow Per Share TTM	4.40	3.93	3.54	0.51	-1.87	-2.44	-3.60	-5.85	-6.19	-5.07	-4.24	-1.25
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	59.09%	59.92%	60.28%	59.79%	59.47%	59.36%	59.34%	60.71%	62.40%	63.77%	66.14%	69.05%
Operating Profit Margin TTM	14.85%	17.93%	16.94%	14.41%	10.76%	8.49%	7.84%	-0.22%	-4.79%	-11.89%	-19.87%	-10.14%
Net Profit Margin TTM	27.04%	31.43%	16.20%	13.49%	10.03%	8.03%	8.14%	0.84%	-3.43%	-10.36%	-18.65%	-11.77%
Growth Metrics
Net Revenue Growth (1Y)	30.24%	37.13%	41.20%	48.09%	64.43%	82.74%	109.09%	137.47%	149.23%	158.53%	167.34%	193.70%
Net Income Growth (1Y)	251.23%	436.58%	181.16%	2,288.73%	-580.13%	-241.70%	-191.22%	-116.87%	-63.98%	-30.92%	-15.17%	-62.73%
EPS Growth (1Y)	244.46%	424.52%	175.63%	2,232.87%	-566.44%	-238.66%	-188.96%	-116.58%	-64.53%	-37.21%	-21.37%	-67.95%
Valuation Metrics
P/E TTM	19.88	21.73	41.71	63.42	46.35	58.42	160.86	1,662.82	-237.60	-102.55	-49.91	-153.70
P/B TTM	6.92	8.74	10.78	14.29	8.52	9.06	25.01	26.27	15.19	18.71	14.12	18.82
P/S TTM	5.38	6.83	6.76	8.55	4.65	4.69	13.09	13.90	8.16	10.62	9.31	18.09
Market Cap	3.42B	4.14B	3.83B	4.54B	2.27B	2.07B	5.25B	4.99B	2.42B	2.57B	1.79B	2.73B
Enterprise Value	3.75B	4.11B	3.82B	4.59B	2.41B	2.18B	5.37B	5.07B	2.52B	2.62B	1.80B	2.60B
Calculated Values
Free Cash Flow TTM	151.36M	133.59M	120.65M	17.35M	-63.23M	-80.94M	-120.51M	-193.76M	-202.89M	-164.88M	-138.16M	-40.78M
Net Debt	332.18M	-26.06M	-9.59M	50.29M	140.01M	112.79M	119.14M	85.28M	97.62M	51.83M	18.84M	-137.20M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Sale

Owner: Gunderson, Thomas J.

Title: -

Shares: 9,624

Price/Share: $75.06

Value: $722,377.44

Shares Owned: 16,642

Relationship: Director

Ownership: Direct

2026-03-04Sale

Owner: Weill, David

Title: -

Shares: 3,571

Price/Share: $146.82

Value: $524,294.22

Shares Owned: 12,134

Relationship: Director

Ownership: Direct

2026-03-04Sale

Owner: Hernandez, Gerardo

Title: Chief Financial Officer

Shares: 7,236

Price/Share: $147.21

Value: $1,065,211.56

Shares Owned: 14,689

Relationship: Officer

Ownership: Direct

2026-03-04Sale

Owner: Lovell, Stephanie

Title: -

Shares: 1,193

Price/Share: $149.62

Value: $178,496.66

Shares Owned: 2,866

Relationship: Director

Ownership: Direct

2026-03-02Sale

Owner: Ranganath, Anil P.

Title: See remarks

Shares: 864

Price/Share: $139.12

Value: $120,199.68

Shares Owned: 13,091

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Gunderson, Thomas J.	Director	-	Direct	Sale	9,624	75.06	$722,377.44	16,642	4
2026-03-04	Weill, David	Director	-	Direct	Sale	3,571	146.82	$524,294.22	12,134	4
2026-03-04	Hernandez, Gerardo	Officer	Chief Financial Officer	Direct	Sale	7,236	147.21	$1,065,211.56	14,689	4
2026-03-04	Lovell, Stephanie	Director	-	Direct	Sale	1,193	149.62	$178,496.66	2,866	4
2026-03-02	Ranganath, Anil P.	Officer	See remarks	Direct	Sale	864	139.12	$120,199.68	13,091	4
2026-03-02	Corcoran, Nicholas	Officer	See remarks	Direct	Sale	2,966	139.12	$412,629.92	29,831	4
2025-12-04	Hernandez, Gerardo	Officer	Chief Financial Officer	Direct	Sale	920	139.62	$128,450.40	15,064	4
2025-12-03	Weill, David	Director	-	Direct	Sale	5,000	138.64	$693,200.00	12,134	4
2025-11-25	Ranganath, Anil P.	Officer	See remarks	Direct	Sale	3,000	145.22	$435,660.00	13,955	4
2025-11-17	Hassanein, Waleed H	Director,Officer	President & CEO	Indirect	Purchase	8,775	114.00	$1,000,350.00	495,009	4
2025-10-29	Basile, Edward M	Director	-	Direct	Sale	4,142	130.45	$540,323.90	2,866	4
2025-08-07	Hassanein, Waleed H	Director,Officer	President & CEO	Indirect	Purchase	8,475	116.46	$986,998.50	486,234	4
2025-08-04	Basile, Edward M	Director	-	Direct	Sale	4,143	125.51	$519,987.93	2,866	4
2025-06-09	Ranganath, Anil P.	Officer	See remarks	Direct	Sale	686	139.80	$95,902.80	13,955	4
2025-05-27	Basile, Edward M	Director	-	Direct	Sale	5,000	126.45	$632,250.00	2,866	4
2025-05-23	Weill, David	Director	-	Direct	Sale	732	123.88	$90,680.16	12,134	4
2025-05-09	Basile, Edward M	Director	-	Direct	Sale	6,000	115.63	$693,780.00	732	4
2025-03-03	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,407	76.43	$183,967.01	36,042	4
2025-01-07	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	1,083	80.05	$86,694.15	20,843	4
2024-12-02	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	1,084	86.40	$93,657.60	20,843	4
2024-11-11	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	1,458	90.04	$131,278.32	20,843	4
2024-11-05	Basile, Edward M	Director	-	Direct	Sale	6,750	83.82	$565,785.00	732	4
2024-11-01	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	1,083	82.64	$89,499.12	20,843	4
2024-10-15	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	8,625	133.50	$1,151,437.50	61,643	4
2024-10-01	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,958	150.34	$444,705.72	20,843	4
2024-09-16	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	8,625	153.84	$1,326,870.00	61,643	4
2024-09-03	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,960	161.28	$477,388.80	20,843	4
2024-08-27	Corcoran, Nicholas	Officer	See Remarks	Direct	Sale	10,000	176.02	$1,760,200.00	21,105	4
2024-08-22	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	25,000	175.00	$4,375,000.00	61,643	4
2024-08-15	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	8,625	169.08	$1,458,315.00	61,643	4
2024-08-08	Tobin, James R	Director	-	Indirect	Sale	20,000	159.46	$3,189,200.00	173,146	4
2024-08-07	Ranganath, Anil P.	Officer	See remarks	Direct	Sale	4,289	152.20	$652,785.80	8,893	4
2024-08-06	Basile, Edward M	Director	-	Direct	Sale	6,750	150.14	$1,013,445.00	732	4
2024-08-01	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,958	158.58	$469,079.64	20,843	4
2024-07-15	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	8,625	145.43	$1,254,333.75	61,643	4
2024-07-01	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,958	151.52	$448,196.16	20,843	4
2024-06-14	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	8,625	142.58	$1,229,752.50	61,643	4
2024-06-05	Basile, Edward M	Director	-	Direct	Sale	1,193	138.08	$164,729.44	732	4
2024-06-03	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,960	132.80	$393,088.00	20,843	4
2024-06-03	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	2,060	135.93	$280,015.80	21,299	4
2024-05-29	Weill, David	Director	-	Direct	Sale	1,193	141.65	$168,988.45	10,732	4
2024-05-29	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	20,000	141.38	$2,827,600.00	21,299	4
2024-05-15	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	8,625	134.98	$1,164,202.50	61,643	4
2024-05-10	Weill, David	Director	-	Direct	Sale	2,500	129.82	$324,550.00	11,193	4
2024-05-07	Basile, Edward M	Director	-	Direct	Sale	7,157	130.44	$933,559.08	1,193	4
2024-05-06	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	15,000	128.00	$1,920,000.00	23,299	4
2024-05-06	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	30,000	130.07	$3,902,100.00	61,643	4
2024-05-06	Corcoran, Nicholas	Officer	See Remarks	Direct	Sale	3,222	129.91	$418,570.02	21,105	4
2024-05-06	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	5,839	130.07	$759,478.73	9,792	4
2024-05-03	Tobin, James R	Director	-	Indirect	Sale	12,025	125.01	$1,503,245.25	193,146	4
2024-05-02	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	12,444	121.82	$1,515,928.08	61,643	4
2024-05-01	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	52,209	115.01	$6,004,557.09	20,843	4/A
2024-05-01	Tobin, James R	Director	-	Indirect	Sale	15,040	107.76	$1,620,710.40	205,171	4
2024-04-17	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	4,000	95.12	$380,480.00	74,087	4
2024-04-10	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	12,000	95.09	$1,141,080.00	74,087	4
2024-04-09	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	15,512	90.62	$1,405,697.44	25,185	4
2024-04-04	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	4,947	80.36	$397,540.92	25,185	4
2024-04-01	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	15,000	74.01	$1,110,150.00	23,299	4
2024-03-08	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	1,903	87.63	$166,759.89	23,299	4
2024-03-08	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	1,417	88.84	$125,886.28	25,185	4
2024-03-04	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	15,000	82.80	$1,242,000.00	25,202	4
2024-03-01	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	10,000	83.37	$833,700.00	26,502	4
2024-03-01	Tobin, James R	Director	-	Indirect	Sale	13,380	83.62	$1,118,835.60	220,211	4
2024-02-20	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	250	90.00	$22,500.00	14,375	4
2024-02-15	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	776	90.00	$69,840.00	14,375	4
2024-02-07	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	736	90.09	$66,306.24	14,375	4
2024-02-06	Basile, Edward M	Director	-	Direct	Sale	7,157	86.55	$619,438.35	8,350	4
2024-02-01	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	15,000	85.45	$1,281,750.00	13,075	4
2024-01-23	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,330	90.09	$209,909.70	14,375	4
2024-01-16	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	10,000	80.73	$807,300.00	14,375	4
2024-01-02	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	15,000	77.07	$1,156,050.00	13,075	4
2023-12-13	Provost, Miriam	Officer	VP, Global Regulatory Affairs	Direct	Sale	4,122	75.10	$309,562.20	23,820	4
2023-12-01	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	7,500	74.65	$559,875.00	506,691	4
2023-11-28	Tobin, James R	Director	-	Indirect	Sale	10,000	70.14	$701,400.00	233,591	4
2023-11-07	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	15,000	64.32	$964,800.00	514,191	4
2023-10-02	Gordon, Stephen	Officer	Chief Financial Officer	Direct	Sale	5,000	54.22	$271,100.00	18,789	4
2023-09-01	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	7,500	67.62	$507,150.00	529,191	4
2023-08-31	Provost, Miriam	Officer	VP, Global Regulatory Affairs	Direct	Sale	2,708	66.52	$180,136.16	23,611	4
2023-08-29	Weill, David	Director	-	Direct	Purchase	2,500	62.00	$155,000.00	13,693	4
2023-08-01	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	7,500	92.86	$696,450.00	536,691	4
2023-07-18	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	5,000	95.37	$476,850.00	14,375	4
2023-07-13	Khayal, Tamer I	Officer	Chief Commercial Officer	Direct	Sale	2,974	90.05	$267,808.70	14,375	4
2023-07-03	Hassanein, Waleed H	Director,Officer	President & CEO	Direct	Sale	7,500	82.67	$620,025.00	544,191	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

102.39%

Inst. Shares: 35,204,893

Shares Outstanding: 34,384,207

2025-12-31

105.89%

Inst. Shares: 35,994,019

Shares Outstanding: 33,993,468

2025-09-30

107.93%

Inst. Shares: 36,816,503

Shares Outstanding: 34,112,452

2025-06-30

104.91%

Inst. Shares: 35,578,475

Shares Outstanding: 33,912,669

2025-03-31

112.83%

Inst. Shares: 38,046,993

Shares Outstanding: 33,721,603

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	35,204,893	34,384,207	102.39%
2025-12-31	35,994,019	33,993,468	105.89%
2025-09-30	36,816,503	34,112,452	107.93%
2025-06-30	35,578,475	33,912,669	104.91%
2025-03-31	38,046,993	33,721,603	112.83%
2024-12-31	35,442,436	33,229,953	106.66%
2024-09-30	33,940,894	33,441,394	101.49%
2024-06-30	31,861,082	33,119,514	96.20%
2024-03-31	32,781,280	32,760,190	100.06%
2023-12-31	33,015,734	32,517,372	101.53%
2023-09-30	33,540,587	32,614,059	102.84%
2023-06-30	30,081,804	32,545,352	92.43%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

TransMedics Group, Inc. (TMDX) — SEC Financial Statements & Analysis

TransMedics Group, Inc. (TMDX) is a electromedical & electrotherapeutic apparatus company, incorporated in MA. TransMedics Group, Inc. trades on Nasdaq as: TMDX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), TransMedics Group, Inc. reported a 30.24% year-over-year revenue growth, a Gross Profit Margin of 59.09% (TTM), a Debt-to-Equity ratio of 1.90x, a Price-to-Sales (P/S) ratio of 5.38x (TTM), a Price-to-Book (P/B) ratio of 6.92 (TTM), at a market cap of $3.42B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 30.24%
Gross Profit Margin TTM: 59.09%
Debt To Equity: 1.90x
P/S TTM: 5.38x
P/B TTM: 6.92
Market Cap: $3.42B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TransMedics Group, Inc. in?

TransMedics Group, Inc. (TMDX) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is TMDX's market cap?

TransMedics Group, Inc. (TMDX) has a market capitalization of $3.42B as of 2026-03-31.

What is TMDX's P/E ratio?

TransMedics Group, Inc. (TMDX)'s trailing twelve month P/E ratio is 19.88x as of 2026-03-31.

What exchange does TMDX trade on?

TransMedics Group, Inc. (TMDX) trades on the Nasdaq.

Where is TransMedics Group, Inc. incorporated?

TransMedics Group, Inc. is incorporated in MA.

TransMedics Group, Inc. (TMDX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.